Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primary vaccination immunogenicity study in preterm infants
NL-OMON44869Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2015
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of rotavirus vaccine 116E in Preventable infectious diseases (VPD) and rotaviral diarrhea (3 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Antibody levels to routine pediatric vaccine components at 5 months and Antibody levels to routine pediatric vaccine components at 12 months. Started Oct 2015; status: active, not recruiting.
02
Drugs
rotavirus vaccine 116E
03
Conditions
Preventable infectious diseases (VPD)rotaviral diarrhea
Beyond the preview
Go deeper on NL-OMON44869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44869.